Article
Optimizing the IMQ model: Deep characterization of the human TLR7 response for early drug development
2024-07-23
Abstract excerpt
<title>Abstract</title> <p>Purpose Imiquimod (IMQ; brand name Aldara®) is a registered topical agent that has been proven to induce local inflammation via the Toll-like receptor (TLR)7 pathway. The purpose of this study was to characterize TLR7-mediated inflammation following 7 days (168h) of topical IMQ exposure in healthy volunteers, and to compare the effects of short exposure (48h-72h) with prolonged exposur...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56a31758-dc1b-5acf-893b-610b4faaef45
- DOI
- 10.21203/rs.3.rs-4655296/v1
